Riou JF - Search Results

1

Structure-activity relation in camptothecin antitumor drugs: why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?

Chourpa I, Beljebbar A, Sockalingum GD, Riou JF, Manfait M. Chourpa I, et al. Among authors: riou jf. Biochim Biophys Acta. 1997 Mar 15;1334(2-3):349-60. doi: 10.1016/s0304-4165(96)00113-4. Biochim Biophys Acta. 1997. PMID: 9101731

2

Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy.

Chourpa I, Morjani H, Riou JF, Manfait M. Chourpa I, et al. Among authors: riou jf. FEBS Lett. 1996 Nov 11;397(1):61-4. doi: 10.1016/s0014-5793(96)01141-6. FEBS Lett. 1996. PMID: 8941714 Free article.

3

Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy.

Chourpa I, Millot JM, Sockalingum GD, Riou JF, Manfait M. Chourpa I, et al. Among authors: riou jf. Biochim Biophys Acta. 1998 Mar 2;1379(3):353-66. doi: 10.1016/s0304-4165(97)00115-3. Biochim Biophys Acta. 1998. PMID: 9545598

4

Molecular and cellular interactions between intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy.

Morjani H, Riou JF, Nabiev I, Lavelle F, Manfait M. Morjani H, et al. Among authors: riou jf. Cancer Res. 1993 Oct 15;53(20):4784-90. Cancer Res. 1993. PMID: 8402662

5

Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA.

Chourpa I, Riou JF, Millot JM, Pommier Y, Manfait M. Chourpa I, et al. Among authors: riou jf. Biochemistry. 1998 May 19;37(20):7284-91. doi: 10.1021/bi972902r. Biochemistry. 1998. PMID: 9585542

6

Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action.

Nabiev I, Fleury F, Kudelina I, Pommier Y, Charton F, Riou JF, Alix AJ, Manfait M. Nabiev I, et al. Among authors: riou jf. Biochem Pharmacol. 1998 Apr 15;55(8):1163-74. doi: 10.1016/s0006-2952(97)00508-x. Biochem Pharmacol. 1998. PMID: 9719470

7

Molecular interactions of DNA-topoisomerase I and II inhibitor with DNA and topoisomerases and in ternary complexes: binding modes and biological effects for intoplicine derivatives.

Nabiev I, Chourpa I, Riou JF, Nguyen CH, Lavelle F, Manfait M. Nabiev I, et al. Among authors: riou jf. Biochemistry. 1994 Aug 2;33(30):9013-23. doi: 10.1021/bi00196a020. Biochemistry. 1994. PMID: 8043587

8

DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.

Feofanov AV, Baranov AV, Fleury F, Riou JF, Nabiev IR, Manfait M. Feofanov AV, et al. Among authors: riou jf. FEBS Lett. 1996 Nov 4;396(2-3):289-92. doi: 10.1016/0014-5793(96)01118-0. FEBS Lett. 1996. PMID: 8915005 Free article.

9

Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.

Riou JF, Fossé P, Nguyen CH, Larsen AK, Bissery MC, Grondard L, Saucier JM, Bisagni E, Lavelle F. Riou JF, et al. Cancer Res. 1993 Dec 15;53(24):5987-93. Cancer Res. 1993. PMID: 8261412

10

Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.

Poddevin B, Riou JF, Lavelle F, Pommier Y. Poddevin B, et al. Among authors: riou jf. Mol Pharmacol. 1993 Oct;44(4):767-74. Mol Pharmacol. 1993. PMID: 8232227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters